Stay updated with breaking news from John Levine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
After collaborating with Diana Ross and Jon Batiste, the artist dishes about pulling herself up by the bootstraps and how she's paying it forward with The Songwriter Fund
>> john is from greenpeace and spends his days and nights tracking ship movements. specifically tankers leaving russia with russian oil. >> through proper pry tore software and open source tools we can track and figure out what the cargo is, where it's going and who the potential buyers are. >> his goal is to help ukraine by either catching cheaters part of an oil embargo or shaming countries and companies who are aiding russia's war effort with blood money. >> since 2014 when russia invaded crimea you've tracked over $90 billion into russia from western countries alone. >> oil and gas is fund...
About how we can't confirm it which are bogus. this information doesn't come from the hard drive. it comes from the obama-era white house visitor logs publicly available. i urge everyone to look at them. they are large, unwieldy files but can be downloaded and you can look and see the meetings. they're there plain as day. >> bill: john, thank you. interesting reporting. >> dana: you think there is more to come? >> i know there is more to come. >> dana: we'd love to see you back. thank you so much. president zelenskyy's top economic adviseor says countries still buying oil from russia are partn...
>> think about the pattern. first tony bobulinski, another business partner an eyewitness a year half ago saying he met with joe biden. now joe biden 19 times meeting with another business partner but saying i have nothing to do with it. we know it wasn't true. >> bill: jim jordan reacting to the post that hunter biden's business partner made at least 19 visits to the white house and other locations listed in the visitor logs on the headlines hunter's west wing man. john levine. hunter biden's business associate schwerin had access to the vice president's personal finances. why? >> i can't rea...
Share: Company Plans to Commence New Pivotal, Randomized Phase 3 Study Evaluating T-Guard ® Versus Ruxolitinib in Patients with Grade III or IV Steroid-refractory Acute Graft-Versus-Host Disease in Second Half of 2021 Positive Results Expected to Support Both FDA and EMA Regulatory Submissions NIJMEGEN, the Netherlands, July 19, 2021 (GLOBE NEWSWIRE) -- Xenikos B.V., a privately-held biotechnology company that develops innovative immunotherapies for treating patients with severe immune disease and post-transplant rejection, today announced that it has reached agreement with the US Food and...